MXB-004

N/A

Report date: 2024/11/06 16:55:41
NME

Base Information

Drug NameMXB-004
Drug Alias NameMXB-004MXB-4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRecombinant envelope protein inhibitors
TargetsRecombinant envelope protein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Herpes Labialis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMaxwell Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesMaxwell Biosciences Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Herpes Labialis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A